Index of medicine substances

Obeticolic acid  •  Alimentary tract and metabolism | Bile therapy | Bile acids and derivatives (A05AA04)

Obidoxime chloride  •  Various | All other therapeutic products | All other therapeutic products | Antidotes (V03AB13)

Obinutuzumab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors (L01FA03)

Ocrelizumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Monoclonal antibodies (L04AG08)

Ocriplasmin  •  Sensory organs | Other ophthalmologicals (S01XA22)

Octenidine  •  Respiratory system | Throat preparations | Throat preparations | Antiseptics (R02AA21)

Octenidine + phenoxyethanol  •  Dermatologicals | Antiseptics and disinfectants | Antiseptics and disinfectants | Quaternary ammonium compounds (D08AJ57)

Octocog alfa  •  Blood and blood forming organs | Vitamin k and other hemostatics | Blood coagulation factors (B02BD02)

Octreotide  •  Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Somatostatin and analogues (H01CB02)

Odevixibat  •  Alimentary tract and metabolism | Bile therapy | Other drugs for bile therapy (A05AX05)

Ofatumumab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors (L01FA02)

Ofloxacin  •  Sensory organs | Antiinfectives | Fluoroquinolones (S01AE01)

Olanzapine  •  Nervous system | Antipsychotics | Diazepines, oxazepines, thiazepines and oxepines (N05AH03)

Olaparib  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents (L01XX46)

Olaratumab  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents | Monoclonal antibodies (L01XC27)

Olezarsen  •  ()

Olipudas alfa  •  Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Enzymes (A16AB25)

Olmesartan medoxomil  •  Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain (C09CA08)

Olmesartan medoxomil + amlodipine  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers (C09DB02)

Olmesartan + amlodipine  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers (C09DB02)

Olmesartan + amlodipine + hydrochlorothiazide  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs), other combinations (C09DX03)

Olmesartan + hydrochlorothiazide  •  Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics (C09DA08)

Olodaterol  •  Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists (R03AC19)

Olopatadine  •  Sensory organs | Decongestants and antiallergics | Other antiallergics (S01GX09)

Olopatadine + mometasone  •  Respiratory system | Decongestants and other nasal preparations for topical use | Corticosteroids (R01AD59)

Omalizumab  •  Respiratory system | Other systemic drugs for obstructive airway diseases (R03DX05)

Omaveloxolon  •  Nervous system | Other nervous system drugs | Other nervous system drugs (N07XX25)

Ombitasvir + paritaprevir + ritonavir  •  Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections (J05AP53)

Omega-3-ethyl esters 90  •  Cardiovascular system | Lipid modifying agents | Lipid modifying agents, plain | Other lipid modifying agents (C10AX06)

Omeprazole  •  Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors (A02BC01)